Global Fund To Stop Purchasing Generic Malaria Medication From Indian Manufacturer After U.S. Regulatory Warning

Reuters: India’s IPCA says Global Fund stops buying its anti-malarial drugs
“India’s IPCA Laboratories Ltd said on Thursday that the Global Fund to Fight AIDS, Tuberculosis and Malaria would no longer buy the company’s anti-malarial treatments after a U.S. regulatory warning about quality lapses at its factories…” (Wilkes, 4/7).